Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up-Reference-Cited by-同舟云学术

Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up

Published:2011-08-08 Issue:9 Volume:26 Page:1074-1083
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:

Author:

Ahmed A.R.,Gürcan H.M.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2011.04205.x/fullpdf

Reference40 articles.

1. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita;Remington;Curr Dir Autoimmun,2008

2. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy;Ishii;Br J Dermatol,2004

3. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group;Bernard;Arch Dermatol,1995

4. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita;Chen;J Invest Dermatol,1997

5. Epidermolysis bullosa acquisita: concise review and practical considerations;Lehman;Int J Dermatol,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center;Medicina;2023-07-07

2. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy;Experimental Dermatology;2023-05-07

3. Epidermolysis Bullosa Acquisita—Current and Emerging Treatments;Journal of Clinical Medicine;2023-02-01

4. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita;Frontiers in Immunology;2022-10-13

5. Epidermolysis bullosa acquisita: an uncommon cause of esophageal stricture;Oxford Medical Case Reports;2021-04-01